Goodwin Procter, Forooghian + Company Law Corporation and Koffman Kalef advised Vizsla Silver Corp., while Skadden and Cassels Brock & Blackwell advised the Underwriters in the...
Vizsla Silver Corp.’s $65 Million Bought Deal Financing
NAPCO Security Technologies’ $74 Million Offering
Goodwin advised the joint underwriters on the deal. NAPCO Security Technologies, Inc. (NASDAQ: NSSC), one of the leading manufacturers and designers of high-tech electronic security devices,...
Genenta Science S.p.A.’s Initial Public Offering On Nasdaq
IN BRIEF: Emmet, Marvin & Martin, LLP, Giovannelli e Associati Studio Legale, Goodwin Procter, Loeb & Loeb LLP, Spada Partners, advised on the matter. Emmet, Marvin...
Genenta Science S.p.A.’s Initial Public Offering On Nasdaq
Goodwin Procter advised the underwriters on the deal. Genenta Science S.p.A.’s (Nasdaq: GNTA) announced its upsized initial public offering, making history as the first Italian biotech to...
Femasys’ $34.45 Million IPO
Goodwin Procter advised the underwriters on the deal, while Dechert advised Femasys. Chardan, a global investment bank, announced that it acted as lead left bookrunner in...
Cutera’s $138.25 Million Notes Offering
Goodwin Procter LLP advised the initial purchasers on the deal. Cutera, Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with Stifel, Nicolaus & Company,...
Alpha Healthcare Acquisition Corp.’s $ 1.1 Billion Business Combination With Humacyte, Inc.
Goodwin Procter LLP advised Alpha Healthcare Acquisition Corp. on the deal. Covington & Burling LLP advised Humacyte, Inc. on the deal.Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC)...